NZMP, Fonterra's b2b dairy ingredients and solutions arm, is exploring the benefits to babies of products containing milk fat globule membrane (MFGM), which is contained in two NZMP commercial ingredients, SureStart MFGM Lipid 100 and 70. The research was funded by a grant from Dairy NZ and the New Zealand Ministry for Primary Industries (MoPI) through its National Innovation Fund.
NZMP, Fonterra's b2b dairy ingredients and solutions arm, is exploring the benefits to babies of products containing milk fat globule membrane (MFGM), which is contained in two NZMP commercial ingredients, SureStart MFGM Lipid 100 and 70. Dr Sophie Gallier, a senior research scientist for NZMP, said MFGM lipids in breast milk are key to brain development early in life, and may come to be regarded among the infant formula industry as the "new docosahexaenoic acid", or DHA, the main lipid which is currently found in baby formula and has a role in developing brain function.